Deutsche Bank launches ETF linked to S&P CNX Nifty index

Frankfurt-based Deutsche Bank has launched the first internationally traded exchange-traded fund (ETF) linked to the Standard & Poor's CNX Nifty, an index on the National Stock Exchange of India.

The db x-trackers S&P CNX Nifty ETF, which will be listed on the Frankfurt Stock Exchange, is one of 41 new ETFs launched by Deutsche Bank over the past few weeks.

“The db x-trackers S&P CNX Nifty ETF provides investors in Europe with a convenient and efficient way to gain exposure to one of the world’s fastest growing economies,” said Thorsten Michalik, head of ETFs at Deutsche Bank. “The S&P CNX Nifty is the flagship index for the Indian stock market and we are pleased to be launching the first ETF on this benchmark outside India.”

The S&P CNX Nifty tracks the behaviour of a portfolio of blue-chip companies, the largest and most liquid Indian securities. It is a diversified 50-stock index providing exposure to 22 sectors of the Indian economy. As at June 30, it represented approximately 55% of the total market capitalisation of the Indian stock market. The S&P CNX Nifty is owned and managed by India Index Services and Products, and is computed using prices of stocks traded on the National Stock Exchange of India, the country’s largest stock exchange.

The fund has an annual all-in fee of 0.85% and will be traded in euros on the Frankfurt Stock Exchange. Deutsche Bank plans to list the ETF on other European stock exchanges in the weeks ahead including the UK, Switzerland, Italy and France.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here